▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | Italian Channel Awards | Italian Project Awards | Italian Security Awards | ...
InnovationOpenLab

ValGenesis VLMS Chosen to Simplify Validation Complexity for Major U.S. Healthcare Provider

ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), announced today that a major healthcare provider in the U.S., delivering high-quality services through ...

Business Wire

SANTA CLARA, Calif.: ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), announced today that a major healthcare provider in the U.S., delivering high-quality services through a complex network of medical institutions, has chosen ValGenesis VLMS to simplify validation complexity and achieve seamless FDA compliance.

The institution’s existing validation activities rely on a combination of disparate applications and manual procedures, resulting in fragmented information stored across locations and formats. This fragmented approach complicates audits and overall regulatory compliance. ValGenesis VLMS was chosen to streamline the entire FDA computer system validation (CSV) lifecycle and provide robust role-based security to ensure data integrity and full 21 CFR Part 11 compliance.

Furthermore, the VLMS will govern both regulated and nonregulated systems, enabling seamless deviation tracking, and provide electronic execution and approval, ensuring full traceability to all testing and configurations. ValGenesis VLMS eliminates the need for time-intensive protocol re-creation, potentially saving the institution hundreds of hours per month. By leveraging decision trees, the system can automatically create protocols simply by answering predefined questions aligned with the institution’s SOPs, ensuring both consistency and efficiency in authoring. Dynamic data visualizations will ensure clarity into validation activities across the enterprise, and enhanced analytics tools will provide valuable insights that will enable the institution to make objective, data-driven decisions.

"As healthcare regulations evolve, ValGenesis VLMS empowers such institutions to adapt seamlessly. Our platform natively supports critical features like risk-based testing and provides intelligent insights across validation activities to unlock unprecedented operational efficiency. We are thrilled to be able to digitally transform this renowned institution and advance its vital healthcare services across the US," said Steve Reynolds, ValGenesis’ chief revenue officer.

ABOUT VALGENESIS

ValGenesis Inc. is the creator of an innovative software platform that is a foundation for managing compliance-based validation activities in life sciences companies. ValGenesis Inc. is the provider of the first enterprise application that manages the corporate validation lifecycle process. This solution is fully compliant with U.S. FDA 21 CFR Part 11 and EU Annex 11 requirements. As the first fully paperless solution for electronic management of validation execution and approval, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award in 2005. For more information, visit www.valgenesis.com.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

RSA at Cybertech Europe 2024

Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…

Italian Security Awards 2024: G11 Media honours the best of Italian cybersecurity

G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes

How Austria is making its AI ecosystem grow

Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries

Sparkle and Telsy test Quantum Key Distribution in practice

Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…

Most read

Alibaba Group Announces March Quarter 2025 and Fiscal Year 2025 Results

$BABA #alibaba--Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and 89988 (RMB Counter), “Alibaba”, “Alibaba Group” or the “company”)…

U.S. Data Center Construction Market Outlook Report 2025-2030 Featuring…

The "U.S. Data Center Construction Market - Industry Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The…

Australia Social Commerce Intelligence Databook 2025: An $8.58 Billion…

The "Australia Social Commerce Market Intelligence and Future Growth Dynamics Databook - 50+ KPIs on Social Commerce Trends by End-Use Sectors, Operational…

J.D. Power Names Joshua Peirez New CEO

J.D. Power today announced that Joshua Peirez will assume the role of President and CEO of J.D. Power, guiding the company in its next phase of growth…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!